Global Molecular Transport Medium Market

Molecular Transport Medium Comprehensive Study by Type (Viral Transport Medium, Virus Swabs), Indication (Mumps Virus, Influenza, Rhinovirus, Adenovirus, COVID-19, Other), End User (Diagnostic Laboratories, Microbiology Laboratories, Hospitals & Clinics, Others) Players and Region - Global Market Outlook to 2027

Molecular Transport Medium Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Molecular Transport Medium?
The demand for molecular transport medium is being driven by an increase in the number of experiments conducted in laboratories and research institutes, increased awareness of laboratory coworker health, rapid antigen testing, and molecular assay experiments, an increase in the number of diagnostic market players, and an increase in the number of infectious diseases such as influenza. Because it inactivates the virus or pathogen, Molecular Transport Medium (MTM) is the safest alternative for transportation, whereas samples held in traditional transport mediums, such as viral transport medium or universal transport medium, will remain infectious and pose safety issues.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledThermo Fisher Scientific (United States), BD (United States), Medical Wire & Equipment (United Kingdom), COPAN Diagnostics Inc. (United States), Titan Biotech Ltd (India), EKF Diagnostics (United Kingdom), Trinity Biotech (Ireland) and Puritan Medical Products (United States)


The study covers a detailed analysis segmented by key business segments i.e. by type (Viral Transport Medium and Virus Swabs) and major geographies. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Molecular Transport Medium market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Molecular Transport Medium market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Thermo Fisher Scientific (United States), BD (United States), Medical Wire & Equipment (United Kingdom), COPAN Diagnostics Inc. (United States), Titan Biotech Ltd (India), EKF Diagnostics (United Kingdom), Trinity Biotech (Ireland) and Puritan Medical Products (United States).

Market Overview:
PrimeStore MTM (Molecular Transport Medium) was designed and optimized for molecular testing allowing pathogenic samples to be collected, transported, and processed safely and efficiently. Millions of tubes of PrimeStore MTM have been sold to clients around the world during the SARS-CoV-2 pandemic.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Market Trend
Rising expenditure by the government to develop healthcare processes and technologies

Opportunities
Increasing number of experiments at labs and research institutes and Rising number of players in the diagnostic market

Key highlights of the Global Molecular Transport Medium market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Molecular Transport Medium market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global Molecular Transport Medium market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Molecular Transport Medium Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Molecular Transport Medium market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Molecular Transport Medium market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Molecular Transport Medium Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End-Users and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Viral Transport Medium
  • Virus Swabs
By Indication
  • Mumps Virus
  • Influenza
  • Rhinovirus
  • Adenovirus
  • COVID-19
  • Other

By End User
  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising awareness for the health of co-workers in the laboratory
      • 3.2.2. Surge in the number of infectious diseases like influenza
    • 3.3. Market Challenges
      • 3.3.1. Streight Government Regulation
    • 3.4. Market Trends
      • 3.4.1. Rising expenditure by the government to develop healthcare processes and technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Transport Medium, by Type, Indication, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Molecular Transport Medium (Value)
      • 5.2.1. Global Molecular Transport Medium by: Type (Value)
        • 5.2.1.1. Viral Transport Medium
        • 5.2.1.2. Virus Swabs
      • 5.2.2. Global Molecular Transport Medium by: Indication (Value)
        • 5.2.2.1. Mumps Virus
        • 5.2.2.2. Influenza
        • 5.2.2.3. Rhinovirus
        • 5.2.2.4. Adenovirus
        • 5.2.2.5. COVID-19
        • 5.2.2.6. Other
      • 5.2.3. Global Molecular Transport Medium by: End User (Value)
        • 5.2.3.1. Diagnostic Laboratories
        • 5.2.3.2. Microbiology Laboratories
        • 5.2.3.3. Hospitals & Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Molecular Transport Medium Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Molecular Transport Medium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BD (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medical Wire & Equipment (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. COPAN Diagnostics Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Titan Biotech Ltd (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EKF Diagnostics (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Trinity Biotech (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Puritan Medical Products (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Molecular Transport Medium Sale, by Type, Indication, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Molecular Transport Medium (Value)
      • 7.2.1. Global Molecular Transport Medium by: Type (Value)
        • 7.2.1.1. Viral Transport Medium
        • 7.2.1.2. Virus Swabs
      • 7.2.2. Global Molecular Transport Medium by: Indication (Value)
        • 7.2.2.1. Mumps Virus
        • 7.2.2.2. Influenza
        • 7.2.2.3. Rhinovirus
        • 7.2.2.4. Adenovirus
        • 7.2.2.5. COVID-19
        • 7.2.2.6. Other
      • 7.2.3. Global Molecular Transport Medium by: End User (Value)
        • 7.2.3.1. Diagnostic Laboratories
        • 7.2.3.2. Microbiology Laboratories
        • 7.2.3.3. Hospitals & Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Molecular Transport Medium Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Transport Medium: by Type(USD Million)
  • Table 2. Molecular Transport Medium Viral Transport Medium , by Region USD Million (2016-2021)
  • Table 3. Molecular Transport Medium Virus Swabs , by Region USD Million (2016-2021)
  • Table 4. Molecular Transport Medium: by Indication(USD Million)
  • Table 5. Molecular Transport Medium Mumps Virus , by Region USD Million (2016-2021)
  • Table 6. Molecular Transport Medium Influenza , by Region USD Million (2016-2021)
  • Table 7. Molecular Transport Medium Rhinovirus , by Region USD Million (2016-2021)
  • Table 8. Molecular Transport Medium Adenovirus , by Region USD Million (2016-2021)
  • Table 9. Molecular Transport Medium COVID-19 , by Region USD Million (2016-2021)
  • Table 10. Molecular Transport Medium Other , by Region USD Million (2016-2021)
  • Table 11. Molecular Transport Medium: by End User(USD Million)
  • Table 12. Molecular Transport Medium Diagnostic Laboratories , by Region USD Million (2016-2021)
  • Table 13. Molecular Transport Medium Microbiology Laboratories , by Region USD Million (2016-2021)
  • Table 14. Molecular Transport Medium Hospitals & Clinics , by Region USD Million (2016-2021)
  • Table 15. Molecular Transport Medium Others , by Region USD Million (2016-2021)
  • Table 16. South America Molecular Transport Medium, by Country USD Million (2016-2021)
  • Table 17. South America Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 18. South America Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 19. South America Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 20. Brazil Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 21. Brazil Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 22. Brazil Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 23. Argentina Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 24. Argentina Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 25. Argentina Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 26. Rest of South America Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 27. Rest of South America Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 28. Rest of South America Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 29. Asia Pacific Molecular Transport Medium, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 31. Asia Pacific Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 32. Asia Pacific Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 33. China Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 34. China Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 35. China Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 36. Japan Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 37. Japan Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 38. Japan Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 39. India Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 40. India Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 41. India Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 42. South Korea Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 43. South Korea Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 44. South Korea Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 45. Taiwan Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 46. Taiwan Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 47. Taiwan Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 48. Australia Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 49. Australia Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 50. Australia Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 54. Europe Molecular Transport Medium, by Country USD Million (2016-2021)
  • Table 55. Europe Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 56. Europe Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 57. Europe Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 58. Germany Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 59. Germany Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 60. Germany Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 61. France Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 62. France Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 63. France Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 64. Italy Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 65. Italy Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 66. Italy Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 67. United Kingdom Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 68. United Kingdom Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 69. United Kingdom Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 70. Netherlands Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 71. Netherlands Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 72. Netherlands Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 73. Rest of Europe Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 74. Rest of Europe Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 75. Rest of Europe Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 76. MEA Molecular Transport Medium, by Country USD Million (2016-2021)
  • Table 77. MEA Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 78. MEA Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 79. MEA Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 80. Middle East Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 81. Middle East Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 82. Middle East Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 83. Africa Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 84. Africa Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 85. Africa Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 86. North America Molecular Transport Medium, by Country USD Million (2016-2021)
  • Table 87. North America Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 88. North America Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 89. North America Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 90. United States Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 91. United States Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 92. United States Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 93. Canada Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 94. Canada Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 95. Canada Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 96. Mexico Molecular Transport Medium, by Type USD Million (2016-2021)
  • Table 97. Mexico Molecular Transport Medium, by Indication USD Million (2016-2021)
  • Table 98. Mexico Molecular Transport Medium, by End User USD Million (2016-2021)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Molecular Transport Medium: by Type(USD Million)
  • Table 108. Molecular Transport Medium Viral Transport Medium , by Region USD Million (2022-2027)
  • Table 109. Molecular Transport Medium Virus Swabs , by Region USD Million (2022-2027)
  • Table 110. Molecular Transport Medium: by Indication(USD Million)
  • Table 111. Molecular Transport Medium Mumps Virus , by Region USD Million (2022-2027)
  • Table 112. Molecular Transport Medium Influenza , by Region USD Million (2022-2027)
  • Table 113. Molecular Transport Medium Rhinovirus , by Region USD Million (2022-2027)
  • Table 114. Molecular Transport Medium Adenovirus , by Region USD Million (2022-2027)
  • Table 115. Molecular Transport Medium COVID-19 , by Region USD Million (2022-2027)
  • Table 116. Molecular Transport Medium Other , by Region USD Million (2022-2027)
  • Table 117. Molecular Transport Medium: by End User(USD Million)
  • Table 118. Molecular Transport Medium Diagnostic Laboratories , by Region USD Million (2022-2027)
  • Table 119. Molecular Transport Medium Microbiology Laboratories , by Region USD Million (2022-2027)
  • Table 120. Molecular Transport Medium Hospitals & Clinics , by Region USD Million (2022-2027)
  • Table 121. Molecular Transport Medium Others , by Region USD Million (2022-2027)
  • Table 122. South America Molecular Transport Medium, by Country USD Million (2022-2027)
  • Table 123. South America Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 124. South America Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 125. South America Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 126. Brazil Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 127. Brazil Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 128. Brazil Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 129. Argentina Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 130. Argentina Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 131. Argentina Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 132. Rest of South America Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 133. Rest of South America Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 134. Rest of South America Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 135. Asia Pacific Molecular Transport Medium, by Country USD Million (2022-2027)
  • Table 136. Asia Pacific Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 137. Asia Pacific Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 138. Asia Pacific Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 139. China Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 140. China Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 141. China Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 142. Japan Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 143. Japan Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 144. Japan Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 145. India Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 146. India Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 147. India Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 148. South Korea Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 149. South Korea Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 150. South Korea Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 151. Taiwan Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 152. Taiwan Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 153. Taiwan Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 154. Australia Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 155. Australia Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 156. Australia Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 157. Rest of Asia-Pacific Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 158. Rest of Asia-Pacific Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 159. Rest of Asia-Pacific Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 160. Europe Molecular Transport Medium, by Country USD Million (2022-2027)
  • Table 161. Europe Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 162. Europe Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 163. Europe Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 164. Germany Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 165. Germany Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 166. Germany Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 167. France Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 168. France Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 169. France Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 170. Italy Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 171. Italy Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 172. Italy Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 173. United Kingdom Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 174. United Kingdom Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 175. United Kingdom Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 176. Netherlands Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 177. Netherlands Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 178. Netherlands Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 179. Rest of Europe Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 180. Rest of Europe Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 181. Rest of Europe Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 182. MEA Molecular Transport Medium, by Country USD Million (2022-2027)
  • Table 183. MEA Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 184. MEA Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 185. MEA Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 186. Middle East Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 187. Middle East Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 188. Middle East Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 189. Africa Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 190. Africa Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 191. Africa Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 192. North America Molecular Transport Medium, by Country USD Million (2022-2027)
  • Table 193. North America Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 194. North America Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 195. North America Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 196. United States Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 197. United States Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 198. United States Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 199. Canada Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 200. Canada Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 201. Canada Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 202. Mexico Molecular Transport Medium, by Type USD Million (2022-2027)
  • Table 203. Mexico Molecular Transport Medium, by Indication USD Million (2022-2027)
  • Table 204. Mexico Molecular Transport Medium, by End User USD Million (2022-2027)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Transport Medium: by Type USD Million (2016-2021)
  • Figure 5. Global Molecular Transport Medium: by Indication USD Million (2016-2021)
  • Figure 6. Global Molecular Transport Medium: by End User USD Million (2016-2021)
  • Figure 7. South America Molecular Transport Medium Share (%), by Country
  • Figure 8. Asia Pacific Molecular Transport Medium Share (%), by Country
  • Figure 9. Europe Molecular Transport Medium Share (%), by Country
  • Figure 10. MEA Molecular Transport Medium Share (%), by Country
  • Figure 11. North America Molecular Transport Medium Share (%), by Country
  • Figure 12. Global Molecular Transport Medium share by Players 2021 (%)
  • Figure 13. Global Molecular Transport Medium share by Players (Top 3) 2021(%)
  • Figure 14. Global Molecular Transport Medium share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 18. BD (United States) Revenue, Net Income and Gross profit
  • Figure 19. BD (United States) Revenue: by Geography 2021
  • Figure 20. Medical Wire & Equipment (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Medical Wire & Equipment (United Kingdom) Revenue: by Geography 2021
  • Figure 22. COPAN Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. COPAN Diagnostics Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Titan Biotech Ltd (India) Revenue, Net Income and Gross profit
  • Figure 25. Titan Biotech Ltd (India) Revenue: by Geography 2021
  • Figure 26. EKF Diagnostics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. EKF Diagnostics (United Kingdom) Revenue: by Geography 2021
  • Figure 28. Trinity Biotech (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Trinity Biotech (Ireland) Revenue: by Geography 2021
  • Figure 30. Puritan Medical Products (United States) Revenue, Net Income and Gross profit
  • Figure 31. Puritan Medical Products (United States) Revenue: by Geography 2021
  • Figure 32. Global Molecular Transport Medium: by Type USD Million (2022-2027)
  • Figure 33. Global Molecular Transport Medium: by Indication USD Million (2022-2027)
  • Figure 34. Global Molecular Transport Medium: by End User USD Million (2022-2027)
  • Figure 35. South America Molecular Transport Medium Share (%), by Country
  • Figure 36. Asia Pacific Molecular Transport Medium Share (%), by Country
  • Figure 37. Europe Molecular Transport Medium Share (%), by Country
  • Figure 38. MEA Molecular Transport Medium Share (%), by Country
  • Figure 39. North America Molecular Transport Medium Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • BD (United States)
  • Medical Wire & Equipment (United Kingdom)
  • COPAN Diagnostics Inc. (United States)
  • Titan Biotech Ltd (India)
  • EKF Diagnostics (United Kingdom)
  • Trinity Biotech (Ireland)
  • Puritan Medical Products (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 153 Pages 75 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Transport Medium Market Quantitative research analysis
Global Molecular Transport Medium Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Molecular Transport Medium Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global Molecular Transport Medium market is dominated by Global Players and may generate healthy valuation by 2027.
  • Rising awareness for the health of co-workers in the laboratory
  • Surge in the number of infectious diseases like influenza
dominated the Molecular Transport Medium market. This is attributable to growing trend of "Rising expenditure by the government to develop healthcare processes and technologies"

Know More About Global Molecular Transport Medium Market Report?

Have a Query? Click Here

Other Related Reports

Home Care - Comprehensive Study by Indication (Cardiovascular Disorders & Hypertension, Respiratory Diseases, Diabetes, Cancer, Wound Care, Pregnancy, Mobility Disorders, Other), Connectivity (CRM, T...
$ 3750
Chikungunya Rapid Testing Comprehensive Study by Technique (Serological testing techniques, Molecular testing techniques), End User (Hospitals, Academic Institutes, Diagnostic Centres, Research Insti...
$ 3350
Homeopathic Injectable Comprehensive Study by Sales Channels (Online Sales Channel, Offline Sales Channels), Types of administration (Subcutaneous Administration, Intraarticular Administration, Peri...
$ 3350
Guided Bone Regeneration Comprehensive Study by Type (Ceramic-based, Polymer-based, Growth factor-based, Cell-based, Others), Application (Orthopedic Surgery, Bone Trauma, Dental Surgery, Others), En...
$ 3650
Electronic Prescription Service Comprehensive Study by Type (Integrated Solutions, Standalone Solutions), Deployment Mode (Cloud-Based, On-Premise), End- User (Hospitals, Office-based Physicians, Pha...
$ 3450
Pets Telehealth - Comprehensive Study by Application (Household, Veterinary Clinics), Platform (IOS, Android), Pricing (Monthly Subscription, Annual Subscription), Features (Virtual consultations, Te...
$ 3450